FMC Corporation
FMC Corporation is classed by the SEC under Chemicals & Allied Products (industry code 2800), based in Philadelphia, PA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $3.5 billion and a loss of $2.2 billion (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 2800, Chemicals & Allied Products); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 4.5 out of ten, 9 of 9 metrics filed: past 6.3 out of ten, present 4.1 out of ten, future 3.3 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 7.5 out of ten. No warning events in its filings since 2017. 75th percentile among 16 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 5.3 out of ten. +3.5% a year over 10 filed years; profitable in 9 of 10. 53rd percentile among 13 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 6.4 out of ten. Share count shrank 0.4% a year. 100% of cash flow returned. Insiders: 1 sales, 3 purchases. 64th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 3.9 out of ten. ROE -107%: lost 107¢ per shareholder dollar. Leverage 78%: owes 78¢ per asset dollar. 39th percentile among 15 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 4.3 out of ten. bottom 43% of 15 in its family; net margin -64.6%. 43rd percentile among 15 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 4.2 out of ten. bottom 42% of 12 in its family for leadership; chief executive since 2024. 42nd percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 5.2 out of ten. top 48% of 15 in its family for room to expand. 52nd percentile among 15 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 1.7 out of ten. bottom 17% of 13 in its family for growth drivers. 17th percentile among 13 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 1.8 out of ten. bottom 18% of 12 in its family for expectations against reality. 18th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-27 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-07-30 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-07-29 (on EDGAR). Newest filing: Form 4, 2026-09-30. Filings on record since 1994. Read from EDGAR 2026-10-12.
Where the revenue comes from
Product and service lines in fiscal 2025: Insecticides 45%, Herbicides 36%, Fungicides 11%, Plant Health 6%, Product and Service Other 3%. By geography: Latin America 39%, North America 32%, Europe, Middle East & Africa 25%, Asia 4%. As tagged in its annual report (Form 10-K, filed 2026-02-27).
Who runs it
Brondeau, Pierre R (Chairman, CEO and President); Sandifer, Andrew D (EVP and CFO); Scanlan, Jacqueline (Executive VP & Chief HRO); Rostovtsev, Vsevolod (EVP & Chief Technology Officer); Pfeiffer, Nicholas (Corporate Controller); Ponessa, Sara (EVP, General Counsel & Sec.); Hugenneyer, Thaisa (EVP, Integrated Supply Chain); Tessenderlo, Group Nv (director); Barry, Michael F (director); Cordeiro, Eduardo E (director); and 11 more. 21 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.